CAH monthly performance report
Check CAH's monthly returns, drawdown, and seasonality trends — updated every month.
CAH monthly report
—
Key takeaways
- Cardinal Health (CAH) closed November 2026 at $278.14, up 11.04% for the month and +36.13% over the trailing 12 months.
- Year-to-date, CAH is +35.35%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +23.73% versus its 200-day moving average ($224.80), a bullish technical signal.
- Over the past three years, CAH has outperformed the S&P 500 by +95.30%, with a relative strength index reading of 154.1.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
Cardinal Health ended November 2026 at $278.14, posting a monthly return of +11.04%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +10.86%.
The current quarter stands at +25.01% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +23.73% versus the 200-day moving average ($224.80).
Year-to-date, CAH is +35.35% against SPY +11.03%, a gap of +24.32%. The stock is currently −2.85% below its 52-week high, with maximum 3-year drawdown at −20.61%.
| Period | CAH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.25% | −0.35% | +0.60% |
| 1 Week | +3.85% | +3.29% | +0.56% |
| 1 Month | +11.04% | +0.19% | +10.86% |
| 3 Months | +18.27% | −2.48% | +20.75% |
| 6 Months | +49.26% | +2.00% | +47.26% |
| YTD | +35.35% | +11.03% | +24.32% |
| 12 Months | +36.13% | +10.79% | +25.34% |
| 3 Years | +167.13% | +71.83% | +95.30% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2025 | +21.54% |
| #2 | Jun 2026 | +20.71% |
| #3 | Nov 2023 | +17.67% |
| #4 | Nov 2024 | +12.64% |
| #5 | Oct 2026 | +12.58% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | −8.72% |
| #2 | Apr 2024 | −7.92% |
| #3 | Mar 2026 | −7.82% |
| #4 | Jul 2025 | −7.61% |
| #5 | Dec 2023 | −5.86% |
| Quarter | Return |
|---|---|
| Q3 2025 | −6.57% |
| Q4 2025 | +30.93% |
| Q1 2026 | +2.83% |
| Q2 2026 | +12.42% |
| Q3 2026 | −6.34% |
| Q4 2026 (QTD) | +25.01% |
| Year | Return |
|---|---|
| 2023 | +31.13% |
| 2024 | +17.33% |
| 2025 | +73.75% |
| 2026 | +35.35% |
| Metric | Value |
|---|---|
| 52-Week High | $286.29 (2026-11-05) |
| 52-Week Low | $180.45 (2026-05-13) |
| Current Price | $278.14 |
| 200-Day Moving Average | $224.80 |
| Price vs 200DMA | +23.73% |
| 3-Year Maximum Drawdown | −20.61% (2026-05-11) |
| Current Drawdown from 52W High | −2.85% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 154.1 |
| 3-Year Excess Return vs S&P 500 | +95.30% |
| RS Peak | 155 (Nov 2026) |
| RS Trough | 70 (Jul 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was CAH's return for this report period?
CAH returned +11.04% in the latest monthly window ending 2026-11-12.
Has CAH outperformed SPY year to date?
YTD CAH: +35.35% vs SPY: +11.03%.
What is CAH's 12-month return?
+36.13% over the trailing 12 months.
Is CAH above or below its 200-day moving average?
Price is +23.73% versus 200DMA ($224.80).
What is the maximum drawdown in the 3-year window?
−20.61% on 2026-05-11.